In 2015, the World Health Organization recommended a urine test that helps with the detection of tuberculosis (TB) in people living with HIV who are hospitalised or who have compromised immune systems. While uptake of this test in South Africa was initially quite slow, numbers presented at the recent South African TB Conference suggest that the use of the test is now increasing. Tiyese Jeranji reports.
South Africa’s tuberculosis (TB) testing numbers have recovered from dramatic declines in 2020, delegates heard at the opening of the 7th South African TB Conference in Durban. The Department of Health also provided some details of its TB recovery plans and targets. Tiyese Jeranji reports from Durban.
The Treatment Action Campaign (TAC) elected new leadership at its recently held seventh national congress. Thabo Molelekwa attended the congress and asked TAC leaders about the organisation’s focus in 2022 and beyond.
Dr Francesca Conradie knew she wanted to be a doctor when she was eight years old. Now, 50 years later, she is a pioneer in the field of tuberculosis (TB) and led a landmark trial that changed how drug-resistant TB is treated. Aisha Abdool Karim spoke to her about the reasons behind her switch from HIV research to TB, her initial surprise at the remarkable NiX trial results, and the man who has shaped her life – her father.
Under a new tuberculosis (TB) diagnosis strategy, people considered to be at high risk of TB are offered molecular TB tests, even if they do not have any symptoms. A landmark study in 2020 showed that such a strategy can help diagnose more people more quickly. Now, early indications are that it also works in the real world and South Africa’s lab service says they can cope with the increased demand. Tiyese Jeranji reports.
The World Health Organization estimates that every year 40% of people who fall ill with TB globally are not diagnosed. There is thus an urgent need for faster, safe, and more convenient TB tests. The current gold standard for testing still requires people to cough up sputum, something that some people and children, in particular, struggle with. Tiyese Jeranji looks at the potential of a new experimental oral swab TB test.
South Africa’s new National Strategic Plan for HIV, TB, and STIs is being developed this year. Spotlight editor Marcus Low asks what we should aim for in the new strategy and how we should go about developing it.
Wieda Human, Ingrid Schoeman, Ruvandhi Nathavitharana, Helene-Mari van der Westhuizen, and Ananja van der Westhuizen from TB Proof argue that we need to look upstream for solutions to improve indoor air quality.
Professor Keertan Dheda has come a long way from growing up as one of three siblings in a one-bedroom apartment in a high-rise in central Durban. Biénne Huisman chatted to Dheda, now the head of the University of Cape Town’s Division of Pulmonology, and a Professor in Mycobacteriology and Global Health at the London School of Hygiene and Tropical Medicine, about work-life balance, problem-solving that excites him, and a career dedicated to the fight against tuberculosis.
While various medicines are produced in South Africa, the active pharmaceutical ingredients going into these medicines are mostly still imported. Catherine Tomlinson reports on a local company that is trying to change that – starting with active pharmaceutical ingredients for tuberculosis and COVID-19 medicines.
The period covered by South Africa’s National Strategic Plan (NSP) for HIV, TB, and STIs 2017 – 2022 will soon come to an end. Against the backdrop of another World TB Day, Tiyese Jeranji asked several local tuberculosis experts what they think the TB priorities should be as South Africa develops an NSP for the next five years.
Long-acting injections have been successfully used as contraception and more recently HIV prevention. Now researchers are exploring whether similar long-acting injections could be used for the prevention and treatment of tuberculosis. Tiyese Jeranji reports.
